{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:48:06Z","timestamp":1783615686467,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.steroids.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T08:37:23Z","timestamp":1400056643000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review"],"prefix":"10.1016","volume":"86","author":[{"given":"Wenxiao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.05.002_b0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/msj.20145","article-title":"A comprehensive approach to the treatment of uterine leiomyomata","volume":"76","author":"Stein","year":"2009","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.steroids.2014.05.002_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2008.11.027","article-title":"Adjuvant gemcitabine plus docetaxel for completely resected stages I\u2013IV high grade uterine leiomyosarcoma: results of a prospective study","volume":"112","author":"Hensley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.steroids.2014.05.002_b0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2014.05.002_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/2141-9248.105656","article-title":"Clinical presentation of uterine fibroids in Nnewi, Nigeria: a 5-year review","volume":"2","author":"Ezeama","year":"2012","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.steroids.2014.05.002_b0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2014.05.002_b0030","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3109\/09513590.2012.638754","article-title":"Current and future medical treatments for menometrorrhagia during the premenopause","volume":"27","author":"Bouchard","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.steroids.2014.05.002_b0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"Therapeutic management of uterine fibroid tumors: updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.steroids.2014.05.002_b0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00006254-200202000-00024","article-title":"Noncontraceptive health benefits of intrauterine devices: a systematic review","volume":"57","author":"Hubacher","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.steroids.2014.05.002_b0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2008.11.004","article-title":"The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis","volume":"79","author":"Sheng","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2014.05.002_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2005.10.029","article-title":"Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) \u2013 a systematic enquiry and overview","volume":"125","author":"Varma","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.steroids.2014.05.002_b0055","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.AOG.0000143824.16435.91","article-title":"Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection","volume":"104","author":"Rauramo","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.steroids.2014.05.002_b0060","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2014.05.002_b0065","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0015-0282(03)00175-4","article-title":"Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas","volume":"79","author":"Grigorieva","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2014.05.002_b0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jmig.2008.08.011","article-title":"The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study","volume":"15","author":"Gunes","year":"2008","journal-title":"J Minim Invasive Gynecol"},{"issue":"Suppl. 4","key":"10.1016\/j.steroids.2014.05.002_b0075","first-page":"S147","article-title":"The use of levonorgestrel \u2013 IUD in the treatment of uterine myoma in Thai women","volume":"89","author":"Jindabanjerd","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.steroids.2014.05.002_b0080","first-page":"613","article-title":"Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas","volume":"50","author":"Rosa e Silva","year":"2005","journal-title":"J Reprod Med"},{"key":"10.1016\/j.steroids.2014.05.002_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Magalhaes","year":"2007","journal-title":"Contraception"},{"issue":"82","key":"10.1016\/j.steroids.2014.05.002_b0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"2010","author":"Zapata","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2014.05.002_b0095","unstructured":"Higgins JPT GSe. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration Available from www.cochrane-handbookorg 2011."},{"key":"10.1016\/j.steroids.2014.05.002_b0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.steroids.2014.05.002_b0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.steroids.2014.05.002_b0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2011.07.031","article-title":"Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma","volume":"116","author":"Kriplani","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.steroids.2014.05.002_b0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/13625187.2011.614028","article-title":"Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and\/or frequent irregular uterine bleeding associated with uterine leiomyoma","volume":"16","author":"Socolov","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.steroids.2014.05.002_b0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2009.09.048","article-title":"Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes","volume":"94","author":"Murat Naki","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2014.05.002_b0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.steroids.2014.05.002_b0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0010-7824(02)00522-X","article-title":"The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia","volume":"67","author":"Mercorio","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2014.05.002_b0135","first-page":"86","article-title":"Estimation of nongravid uterine volume based on a normogram of gravid uterine volume: Its value in gynecologic uterine abnormalities","volume":"72","author":"Goldstein","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.steroids.2014.05.002_b0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1472-6483(10)61919-0","article-title":"Development of a miniature, low-dose, frameless intrauterine levonorgestrel-releasing system for contraception and treatment: a review of initial clinical experience","volume":"4","author":"Wildemeersch","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.steroids.2014.05.002_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00404-008-0871-5","article-title":"Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus","volume":"280","author":"Tasci","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.steroids.2014.05.002_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0010-7824(02)00324-4","article-title":"Contraception and treatment in the perimenopause with a novel \u201cframeless\u201d intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study","volume":"66","author":"Wildemeersch","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2014.05.002_b0155","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bmj.316.7138.1122","article-title":"Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy","volume":"316","author":"Lahteenmaki","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.steroids.2014.05.002_b0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1023\/B:BEBM.0000010962.35909.a1","article-title":"Proliferative activity and level of steroid hormone receptors in the myometrium and myoma nodes in different phases of menstrual cycle","volume":"136","author":"Pavlovich","year":"2003","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.steroids.2014.05.002_b0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.contraception.2010.03.002","article-title":"Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells","volume":"82","author":"Xu","year":"2010","journal-title":"Contraception"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14000993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T01:51:22Z","timestamp":1538617882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14000993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":33,"alternative-id":["S0039128X14000993"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.05.002","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}